- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharma Pulse 7/1/24: AI Frenzy Propels Stocks to Monster First Half, Considerations for Integrating Artificial Intelligence & more
The latest news for pharma industry insiders.
Considerations for Integrating Artificial Intelligence
In part 4 of this video interview, Diane Lacroix, vice president, clinical data management, eClinical Solutions discusses what industry stakeholders should be keeping top of mind when integrating AI into their workflows.
Healthcare Takes Backseat in Biden-Trump Debate. Biden's Age Not So Much
The presidential candidates didn't spend a lot of time talking about healthcare issues last night, but Democrats are concerned about Biden's performance, especially in the early going.
AI Frenzy Propels Stocks to Monster First Half
S&P 500 has climbed 15% despite reduced hopes for Federal Reserve interest-rate cuts.
Global mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2024 - ResearchAndMarkets.com
The "Global mRNA Cancer Vaccines Clinical Trials & Market Future Outlook 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.
Global mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2024 Report Highlights:
- mRNA Cancer Vaccines in Clinical Trials: > 60 Vaccines
- Highest Phase of Clinical Trials: Phase III (2 Vaccine)
- mRNA Cancer Vaccine Clinical Trials Insight by Company, Country, Indication & Phase
- First Commercial mRNA Vaccine Approval Expected by 2029
- US & China Dominating mRNA Cancer Vaccines Clinical Trials: > 45 Vaccines
- mRNA Vaccines for Skin Cancer Dominating Trials: > 10 Vaccines
The future of clinical research focuses on sustainability and patient-centricity. Discover key considerations for greener supply chain management in this piece from @Clin_Trials : https://ow.ly/oYMj50Sq0Ms
Have news you want us to share in Pharma Pulse? Reach out to Social
Media Editor Miranda Schmalfuhs
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
